{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:01:26Z","timestamp":1784088086693,"version":"3.55.0"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T00:00:00Z","timestamp":1194307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Practice"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p><jats:bold>\u25aa\u2002Abstract:\u2003<\/jats:bold>We describe the case of a patient with significant adverse effects from posttraumatic analgesic therapy with opioid analgesics who was found by microarray analysis to have a CYP2D6 genotype predictive of a poor metabolizer phenotype. In addition to her poor tolerance and limited response to opioid analgesics, she developed further discomfort when the antiemetic promethazine was administered to treat her gastrointestinal adverse effects. In our discussion we review the literature about the clinical impact of CYP450 2D6 polymorphisms in treatment with the commonly used opioid analgesics codeine, oxycodone, hydrocodone, hydromorphone, and morphine, as well as the antiemetic promethazine. The case we present, as well as the literature we review, demonstrates the clinical utility of CYP2D6 genotyping in patients with adverse effects from analgesia therapy.\u2002\u25aa<\/jats:p>","DOI":"10.1111\/j.1533-2500.2007.00153.x","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T05:37:14Z","timestamp":1194413834000},"page":"352-356","source":"Crossref","is-referenced-by-count":70,"title":["Complicated Pain Management in a CYP450 2D6 Poor Metabolizer"],"prefix":"10.1111","volume":"7","author":[{"given":"Adriana","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,11,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032424"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005454.pub2"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.3.336"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199610000-00009"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.47.1.75"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.3.2.229"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00021-9"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.03.018"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199710000-00011"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050200"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2005.05106.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.44.6.515"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90051-0"},{"key":"e_1_2_7_15_2","volume-title":"Basic and Clinical Pharmacology.","author":"Schumacher MA","year":"2007"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.4.447"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.02002.x"},{"key":"e_1_2_7_18_2","volume-title":"Family Medicine: Principles and Practice","author":"Larsen LC","year":"2003"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.44.2.167"},{"key":"e_1_2_7_20_2","volume-title":"ACP's PIER: The Physicians' Information and Education Resource","author":"American College of Physicians.","year":"2007"},{"key":"e_1_2_7_21_2","unstructured":"Roche pharmaceuticals. Package insert: Toradol\u00ae (ketolorac tromethamine injection\/tablets).September 2002. Available from:http:\/\/www.rocheusa.com\/products\/toradol\/pi.pdf(accessed February 15 2007)."},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631020-00002"},{"key":"e_1_2_7_23_2","unstructured":"Purdue PharmaLP.Package insert: Oxycontin\u00ae (oxycodone HCl controlled\u2010release) tablets.January 15 2007. Available fromhttp:\/\/www.purduepharma.com\/PI\/Prescription\/Oxycontin.pdf(accessed February 9 2007)."},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.058602"},{"key":"e_1_2_7_25_2","unstructured":"Adverse Events Reported in Clinical Trials page 20. Available from:http:\/\/www.purduepharma.com\/PI.\/prescription\/Palladone.pdf"},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-3565(24)36599-1","article-title":"Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability","volume":"281","author":"Kaplan HL","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"e_1_2_7_27_2","volume-title":"Basic and Clinical Pharmacology","author":"McQuaid KR","year":"2007"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/026988119200600214"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)90202-X"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1054\/ijoa.1999.0346"},{"key":"e_1_2_7_31_2","unstructured":"Purdue PharmaLP.Package insert: MS Contin\u00ae (morphine sulfate controlled\u2010release) tablets.November 3 2005. Available from:http:\/\/www.purduepharma.com\/PI\/Prescription\/MS_Contin.pdf(accessed February 10 2007)."},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.17.2000-b"}],"container-title":["Pain Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1533-2500.2007.00153.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1533-2500.2007.00153.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:04:08Z","timestamp":1737518648000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1533-2500.2007.00153.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,6]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1533-2500.2007.00153.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1533-2500.2007.00153.x","archive":["Portico"],"relation":{},"ISSN":["1530-7085","1533-2500"],"issn-type":[{"value":"1530-7085","type":"print"},{"value":"1533-2500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,6]]}}}